Authors: Rigas, ML Okino, MS Quackenboss, JJ

Citation: Ml. Rigas et al., Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose inchildren, based on urinary biomarker measurements, TOXICOL SCI, 61(2), 2001, pp. 374-381

Authors: Rigas, ML Catlin, SN Ben-Jebria, A Ultman, JS

Citation: Ml. Rigas et al., Ozone uptake in the intact human respiratory tract: relationship between inhaled dose and actual dose, J APP PHYSL, 88(6), 2000, pp. 2015-2022

Authors: Rigas, ML

Citation: Ml. Rigas, Software review: Modelmaker 4.0, RISK ANAL, 20(4), 2000, pp. 543-544

Authors: Rigas, ML

Citation: Ml. Rigas, Communicating uncertainty: Media coverage of new and controversial science, RISK ANAL, 20(2), 2000, pp. 295-296

Authors: Hubal, EAC Sheldon, LS Burke, JM McCurdy, TR Barry, MR Rigas, ML Zartarian, VG Freeman, NCG

Citation: Eac. Hubal et al., Children's exposure assessment: A review of factors influencing children'sexposure, and the data available to characterize and assess that exposure, ENVIR H PER, 108(6), 2000, pp. 475-486

Authors: Zartarian, VG Ozkaynak, H Burke, JM Zufall, MJ Rigas, ML Furtaw, EJ

Citation: Vg. Zartarian et al., A modeling framework for estimating children's residential exposure and dose to chlorpyrifos via dermal residue contact and nondietary ingestion, ENVIR H PER, 108(6), 2000, pp. 505-514